LAI GOLDMAN MYLA 4

What Happened Myla Lai Goldman, a member of the board of directors of West Pharmaceutical Services, received a grant of 791 restricted stock units (transaction code A) on May 4, 2026. The filing shows an acquisition price of $0.00 (granted as compensation); the filing does not state a cash value or market value for the award.

Key Details

• Transaction date: 2026-05-04; Form 4 filed 2026-05-06 (two days later).
• Transaction type: Award/grant of 791 restricted stock units (RSUs), recorded at $0.00 acquisition price.
• Shares owned after the transaction: Not specified in the filing.
• Footnote: These RSUs will vest in full on the date of the next annual shareholder meeting and will be distributable under the Deferred Compensation Plan for Outside Directors.
• No 10b5-1 plan, tax withholding, or sale reported in this filing.

Context This grant is a compensatory award to an outside director and represents future entitlement to shares if and when the RSUs vest and are distributed; it is not an open-market purchase or sale. Such awards are common for non-employee directors and do not by themselves indicate the director’s short-term trading intent.